Adult Endocrinology and Metabolism — Foundation of Discipline

F2 Providing ongoing care for individuals with an uncomplicated presentation of an endocrine condition

Key Features:
- This EPA includes clinical reassessment, further investigation and/or modification of treatment, screening or monitoring for adverse effects or complications of the condition or its treatment, and making decisions about discharge and/or timing of ongoing follow-up.

Assessment Plan:
Direct and/or indirect observation by supervisor, clinical fellow, or TTP resident
Use Form 1. Form collects information on:
- Presentation (write in):
Collect 4 observations of achievement
- At least 1 presentation of diabetes
- At least 3 different presentations other than diabetes
- At least 2 different observers

Form

F1: Observation

Milestones

• ME 1.4. Perform a clinical assessment that addresses all relevant issues

• ME 2.2. Assess adherence to, response to, and adverse effects of therapy as well as complications of the underlying disorder

• ME 2.2. Interpret the results of investigations performed to monitor the condition and/or treatment

• ME 2.2. Determine if there is a need to adapt the management plan based on response to therapy and/or disease progression

• ME 4.1. Determine the frequency and timing of future investigations and visits

• COL 3.1. Determine if care should be transferred back to a primary care provider

• HA 1.2. Work with the patient/family to increase their understanding of the condition and associated comorbidities, supporting their active role in disease management

• COM 5.1. Document the encounter to convey the clinical assessment and the rationale for decisions and/or recommendations

Context Variables

• Presentation (free-text)

Requirements

• Collect 4 observations of achievement (minimum 4)
• At least 1 presentation of diabetes (minimum 1)
• At least 3 different presentations other than diabetes (minimum 3)
• At least 2 different observers (minimum 2)
  • Counted once per distinct Assessor